We Translate Science into Health

Our laboratory identifies therapeutic targets for metabolic disease, including metabolic dysfunction-associated steatohepatitis (MASH) and metabolic dysfunction-associated alcohol-related liver disease (MetALD)-associated liver fibrosis.  We bring together visionary scientists, emerging technologies and world-class networks.